Latest News

May 26, 2010

Health Enhancement Products Announces Details of Its June 8th Scientific Panel Presentation

May 11, 2010

Health Enhancement Products Schedules Press Event June 8 to Present Breakthroughs in Its Cholesterol Management Research

April 26, 2010

Health Enhancement Products Secures Funding Enabling the Company to Begin Phase O Clinical Trials

April 21, 2010

Health Enhancement Products Names Denis M. Callewaert, Ph.D. to Its New Chief Science Officer Position

April 13, 2010

Professor of Molecular Toxicology at Penn State University, Jack Vanden Heuvel PhD, to Join Health Enhancement Products Scientific Advisory Boardt

March 9, 2010

Wayne State University Researchers Discover Potentially New Means to Regulate Bad Cholesterol and Raise HDL (Good Cholesterol) With Bioactive Molecules Derived From ProAlgaZyme(TM) -- a Proprietary Algal Extract

July 20, 2010

Health Enhancement Products Expands Scientific Advisory Board Dr. Donald Armstrong, Noted Expert in Oxidative Stress and Inflammation, Joins as Science Advisor

 


Health Enhancement Products is a member of these organizations







 

Health Enhancement Products, Inc. and HEPI Pharmaceuticals, Inc. Announce Resignation of CEO

Friday September 7, 9:30 pm ET

 
SCOTTSDALE, AZ--(MARKET WIRE)--Sep 7, 2007 -- Health Enhancement Products, Inc. (OTC BB:HEPI.OB - News) and HEPI Pharmaceuticals, Inc., its wholly owned subsidiary, announced today that Thomas D. Ingolia has resigned as director and CEO of the companies. Effective immediately Janet Crance, currently a director and the Chief Accounting Officer of each company, will act as the Chief Administrative Officer of both companies.

About Health Enhancement Products, Inc. and ProAlgaZyme

Health Enhancement Products Inc. is a nutraceutical company engaged in the development of a Dietary Supplement product using only pure, all-natural ingredients. The company's sole product is ProAlgaZyme, a liquid product produced from algae grown in 100% distilled water. The liquid in which the algae are grown is drawn off, filtered, tested and bottled as ProAlgaZyme. HEPI Pharmaceuticals, Inc. is exploring the development of the potential pharmaceutical applications of ProAlgaZyme.

For more information, please visit www.heponline.com.

Contact information:

John Gorman
Email Contact
480-385-3800

 

<< Back to Releases

 

© 2009 HEALTH ENHANCEMENT PRODUCTS INC.
            PRIVACY POLICY           DISCLAIMER